FdaApplication

ANDA 202385

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS
application_typeANDA
approval_date2011-12-16

Products (1)

ProductActive ingredientStrengthDosage form
FELBAMATEFELBAMATE600MG/5MLSUSPENSION;ORAL

1 product